Position-349 BBD29_RS02010 Variant for High-Yield L-Arginine Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for improved methods to efficiently produce L-arginine with high yield using microorganisms.

Innovation Solution

A novel BBD29_RS02010 variant polypeptide, where arginine at position 349 is substituted with glutamine, is used in a microorganism culture to enhance L-arginine production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional methods (increasing expression of arginine biosynthesis genes or deleting unnecessary genes) are used, then L-arginine production is improved, but the yield is still insufficient to meet growing industrial needs

Engineering Contradiction:
ImproveL-arginine production yieldVSAvoidsatisfaction of industrial demand
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by modifying the amino acid sequence of the BBD29_RS02010 enzyme at position 349, substituting arginine with glutamine to create variants with enhanced catalytic activity. This specific parameter change in the enzyme structure results in improved L-arginine production yield that exceeds conventional methods, directly addressing the insufficiency of existing approaches to meet industrial demand

Inventive Principle:
Principle #35Parameter changes

2Productivity

If target material-specific approaches are used (increasing expression of arginine biosynthesis genes), then L-arginine production is enhanced, but the efficiency is limited and further research is needed

Engineering Contradiction:
ImproveL-arginine production efficiencyVSAvoidmethod complexity
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent applies local quality by making a specific localized modification to the BBD29_RS02010 enzyme at position 349, where arginine is substituted with glutamine. This localized change in the enzyme's amino acid sequence creates variants with superior catalytic activity for L-arginine production, achieving high efficiency without requiring complex multi-gene manipulation approaches

Inventive Principle:
Principle #3Local quality

Data Source

PatentEP4610273A1Novel BBD29_RS02010 mutant and method for producing l-arginine using same
Publication Date: 2025.09.03 CJ CHEILJEDANG CORP
  • EP4610273A1 patent drawing
  • EP4610273A1 patent drawing
  • EP4610273A1 patent drawing

AI summary

Provided are a novel BBD29_RS02010 variant polypeptide; a polynucleotide encoding the variant polypeptide; a microorganism comprising any one or more of the variant polypeptide, the polynucleotide encoding the variant polypeptide, and a vector comprising the polynucleotide; and a method of producing L-arginine, the method comprising the step of culturing the microorganism in a medium.